Achieve Life Sciences (ACHV) Interest Coverage Ratio (2018)
Achieve Life Sciences' (ACHV) quarterly Interest Coverage Ratio came in at 0.92 in Q4 2018, up 106.5% YoY from 0.45 in Q4 2017, and up 171.82% on a QoQ basis from 1.28 in Q3 2018.
Analysis
Achieve Life Sciences (ACHV) Interest Coverage Ratio (2018) Analysis & Trends
Achieve Life Sciences (ACHV) has 6 years of Interest Coverage Ratio data on file, last reported at 0.92 in Q4 2018.
- Quarterly Interest Coverage Ratio rose 106.5% year-over-year to 0.92 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 0.82 (down 99.41% YoY) and the FY2019 annual result came in at 92.15, down 12710.48% from the prior year.
- Interest Coverage Ratio advanced to 0.92 in Q4 2018, from 1.28 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.99 in Q1 2017 to a low of 136.22 in Q4 2015.
- A 4-year average of 17.2 and a median of 2.17 in 2016 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 106.5% in 2018, down 213.93% in 2018.
- Tracing ACHV's Interest Coverage Ratio over 4 years: stood at 136.22 in 2015, then jumped by 90.95% to 12.33 in 2016, then dropped by 15.23% to 14.2 in 2017, then jumped by 106.5% to 0.92 in 2018.
- The last three Interest Coverage Ratio figures came in at 0.92 (Q4 2018), 1.28 (Q3 2018), and 0.97 (Q2 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - | - |